CLINICAL_TRIALS
trial_result
· 2010-06-03
Clinical Trial Update: Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg [Phase 1]
Summary
Phase I study in China evaluated the tolerability of a single 30 mg/kg dose of abatacept in lupus nephritis. The results were posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Lupus Nephritis | Phase 1 | Status: COMPLETED | Results posted: 2010-06-03